Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 155,058 shares at $120.37 ($18.7M) on 2023-12-07, disclosed to the SEC on 2023-12-11.
Scheduled sale ($18.7M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.37 | 11,775 | $1.4M | 7.6% |
| 2 | $120.37 | 11,775 | $1.4M | 7.6% |
| 3 | $120.37 | 12,742 | $1.5M | 8.2% |
| 4 | $120.37 | 12,742 | $1.5M | 8.2% |
| 5 | $120.37 | 14,140 | $1.7M | 9.1% |
| 6 | $120.37 | 14,140 |
| $1.7M |
| 9.1% |
| 7 | $120.37 | 38,722 | $4.7M | 25.0% |
| 8 | $120.37 | 38,722 | $4.7M | 25.0% |
| 9 | $120.00 | 100 | $12K | 0.1% |
| 10 | $120.16 | 200 | $24K | 0.1% |
| Total | $120.37 avg | 155,058 | $18.7M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |